LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0. A total of 6 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $25,702,000 | -10.5% | 17,000,000 | 0.0% | 0.01% | -14.3% |
| Q1 2019 | $28,710,000 | -7.1% | 17,000,000 | 0.0% | 0.01% | -17.6% |
| Q4 2018 | $30,906,000 | -50.4% | 17,000,000 | 0.0% | 0.02% | -39.3% |
| Q3 2018 | $62,311,000 | -67.2% | 17,000,000 | -75.4% | 0.03% | -69.9% |
| Q2 2018 | $189,807,000 | +9.7% | 69,000,000 | -12.7% | 0.09% | -1.1% |
| Q1 2018 | $173,042,000 | +110.3% | 79,000,000 | +75.6% | 0.09% | +88.0% |
| Q4 2017 | $82,278,000 | +21.5% | 45,000,000 | +21.6% | 0.05% | -3.8% |
| Q3 2017 | $67,702,000 | +10.4% | 37,000,000 | 0.0% | 0.05% | 0.0% |
| Q2 2017 | $61,305,000 | +11.1% | 37,000,000 | 0.0% | 0.05% | +4.0% |
| Q1 2017 | $55,185,000 | +3.1% | 37,000,000 | 0.0% | 0.05% | -7.4% |
| Q4 2016 | $53,500,000 | +10.7% | 37,000,000 | +12.1% | 0.05% | +10.2% |
| Q3 2016 | $48,329,000 | +25.8% | 33,000,000 | +43.5% | 0.05% | +14.0% |
| Q2 2016 | $38,419,000 | +9.5% | 23,000,000 | 0.0% | 0.04% | -2.3% |
| Q1 2016 | $35,090,000 | +25.9% | 23,000,000 | +27.8% | 0.04% | +46.7% |
| Q4 2015 | $27,874,000 | -6.5% | 18,000,000 | -21.7% | 0.03% | +7.1% |
| Q3 2015 | $29,819,000 | – | 23,000,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|